Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
IPO Year:
Exchange: NYSE
Website: humana.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/3/2024 | $392.00 → $274.00 | Overweight → Neutral | Piper Sandler |
| 10/2/2024 | $376.00 → $247.00 | Neutral → Underperform | BofA Securities |
| 10/2/2024 | $400.00 → $250.00 | Outperform → Market Perform | Leerink Partners |
| 10/2/2024 | $400.00 → $250.00 | Overweight → Equal-Weight | Stephens |
| 6/26/2024 | $392.00 | Overweight | Piper Sandler |
| 6/24/2024 | $374.00 | Equal-Weight | Morgan Stanley |
| 4/2/2024 | $470.00 → $342.00 | Buy → Neutral | BofA Securities |
| 4/2/2024 | Buy → Neutral | BofA Securities | |
| 3/22/2024 | Mkt Perform | Raymond James | |
| 3/13/2024 | Buy → Hold | Argus |
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
Humana Inc. (NYSE:HUM) will release its financial results for the third quarter 2024 (3Q24), as well as prepared management remarks (in PDF format), on Wednesday, October 30, 2024, at 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2024. To participate via telephone, please register in advance using this link, https://register.vevent.com/register/BI66effa11b1e4494d907df29b87d7d237. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique regi
Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on October 25, 2024 to stockholders of record as of the close of business on September 30, 2024. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, mil
Reports 2Q24 earnings per share (EPS) of $5.62 on a GAAP basis, Adjusted EPS of $6.96; reports YTD 2024 EPS of $11.74 on a GAAP basis, $14.19 on an Adjusted basis Revises FY 2024 EPS guidance to 'approximately $12.81' (previously 'approximately $13.93') on a GAAP basis, while affirming Adjusted EPS of 'approximately $16.00'; affirms FY 2024 Insurance segment benefit ratio of approximately 90 percent Raises 2024 individual Medicare Advantage annual membership growth by 75,000 to now anticipate annual growth of approximately 225,000, or 4.2 percent Publishes Letter from the CEO and prepared management remarks to Investor Relations page of www.humana.com ahead of this morning's 9:00
Humana Inc. (NYSE:HUM) will release its financial results for the second quarter 2024 (2Q24), as well as prepared management remarks (in PDF format), on Wednesday, July 31, 2024, at 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2024. To participate via telephone, please register in advance using this link, https://register.vevent.com/register/BI4837b56336d1453fb10a8fdaada5e1c0. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique regi
Reports 1Q24 earnings per share (EPS) of $6.11 on a GAAP basis, Adjusted EPS of $7.23 Revises FY 2024 EPS guidance to 'approximately $13.93' (previously 'approximately $14.87') on a GAAP basis, while affirming Adjusted EPS of 'approximately $16.00'; affirms FY 2024 Insurance segment benefit ratio of approximately 90 percent Raises 2024 individual Medicare Advantage annual membership growth by 50,000 to now anticipate annual growth of approximately 150,000, or 2.8 percent Continues successful track record of organic expansion in Medicaid with recent contract wins in Florida, Texas, and Virginia Publishes prepared management remarks to Investor Relations page of www.humana.com ah
Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on July 26, 2024 to stockholders of record as of the close of business on June 28, 2024. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military se
Humana Inc. (NYSE:HUM) will release its financial results for the first quarter 2024 (1Q24), as well as prepared management remarks (in PDF format), on Wednesday, April 24, 2024, at 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2024. To participate via telephone, please register in advance using this link, https://register.vevent.com/register/BI6d7513be1a494bbb82b4b8caa62d3b2f. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique regi
Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 26, 2024 to stockholders of record as of the close of business on March 29, 2024. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military
Reports 4Q23 loss per share of $4.42 on a GAAP basis, Adjusted loss per share of $0.11; reports FY 2023 earnings per share (EPS) of $20.00 on a GAAP basis, $26.09 on an Adjusted basis 4Q23 results reflect additional increase in Medicare Advantage medical cost trends, driven by higher than anticipated inpatient utilization, primarily for the months of November and December, and a further increase in non-inpatient trends Announces initial FY 2024 EPS guidance of 'approximately $14.87' on a GAAP basis, 'approximately $16.00' on an Adjusted basis; assumes the higher Medicare Advantage medical costs experienced in 4Q23 persist throughout 2024 Affirms 2024 individual Medicare Advantage
Humana Inc. (NYSE:HUM) will release its financial results for the fourth quarter 2023 (4Q23), as well as prepared management remarks (in PDF format), on Thursday, January 25, 2024, at approximately 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2024. The call was originally scheduled for Monday, February 5, but was rescheduled to provide a more timely update on the company's performance and 2024 guidance. To participate via telephone, please register in advance using this link, https://register.vevent.com/register/BI4ed0098679fd435e8af0ab344
Humana is also supporting its members across the affected areas by providing simplified access to medical and emergency prescription information, as well as opening a crisis hotline with free counseling available. The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE:HUM), is donating $1 million towards relief and recovery efforts for those impacted by Hurricane Helene. Humana has also taken steps to aid members and communities in the storm's path, including providing simplified access to medical and emergency prescription information, and opening a crisis hotline with free counseling available. Hurricane Helene made landfall along Florida's Big Bend region on Sept. 26, causin
Humana plans include benefits members say they value most and offer options for a variety of budgets and lifestyles Leading health and well-being company Humana Inc. (NYSE:HUM) today announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241001415731/en/Humana's Medicare Advantage plans are tailored to meet the varying needs of Medicare beneficiaries, providing them with affordable options during the upcoming Medicare Advantage Annual Election Period (AEP) Oct. 15-Dec. 7. Humana has a total of 793 individual Medicare Advantage plans throughout the c
Humana Inc. (NYSE:HUM) will release its financial results for the third quarter 2024 (3Q24), as well as prepared management remarks (in PDF format), on Wednesday, October 30, 2024, at 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2024. To participate via telephone, please register in advance using this link, https://register.vevent.com/register/BI66effa11b1e4494d907df29b87d7d237. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique regi
In advance of Health Literacy Month, CenterWell™ launches CenterWell Presents and Conviva on Demand, libraries of online health information designed as additional resources seniors can use to improve their well-being. The free, online educational material includes live webinars and recorded videos on a variety of senior-focused health topics available at any time to anyone, whether or not they're a CenterWell Senior Primary Care or Conviva Care Center patient. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240930048049/en/ The libraries' content ranges from understanding blood pressure and arthritis to developing sleep habits tha
Leading health and well-being company Humana Inc. (NYSE:HUM), and kidney care management company Interwell Health, have expanded their value-based care agreement to include Florida for eligible Humana Medicare Advantage members living with chronic kidney disease (CKD) and end-stage kidney disease (ESKD). Interwell's value-based support services are now available in 14 states for eligible members with CKD, and in 39 states for eligible members living with ESKD. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240924319017/en/ Value-based care is a holistic, patient-centered healthcare model that focuses on a coordinated effort to he
Mays Business School at Texas A&M University and leading health and well-being company Humana Inc. have kicked off the 2024 Humana-Mays Healthcare Analytics Case Competition. The competition – in its eighth year – is a chance for students to showcase their analytical talents as they solve a real-world business problem. The prize package for the winning teams is $90,000, with $50,000 for first place, $20,000 for second place, $10,000 for third place and $5,000 each for fourth and fifth places. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240919627010/en/ Held virtually, the competition is open to all accredited educational insti
For the third consecutive year, Humana Inc., a leading health and well-being company, is named a Certified™ Great Place To Work®. The prestigious award is based entirely on current employees' experience working at Humana. This year, 81 percent of employees said Humana is "a great place to work" – 24 percentage points higher than the average company. Great Place To Work® is the global authority on workplace culture, employee experience, and leadership behaviors proven to deliver market-leading revenue, employee retention, and increased innovation. The annual recognition sets companies apart as top employers providing a great workplace environment for their employees. "Achieving Great Place
In collaboration with a leading researcher and professor at Harvard University, Humana's first-of-its-kind study found better access to primary care and narrowed racial and socio-economic disparities for those receiving care from senior-focused primary care organizations. Humana Inc. (NYSE:HUM), one of the nation's leading health and well-being companies, recently published a study on senior-focused primary care — a value-based care model that tailors the environment and services of clinical organizations to the unique needs of older adults. Published in Health Affairs, this study is the first of its size and scope in analyzing this type of organization. This joint study, conducted in par
Humana Inc. (NYSE:HUM), a leading health and well-being company, announced a new value-based kidney care program with Evergreen Nephrology designed to advance quality of care and help optimize health outcomes for people living with chronic kidney disease and end-stage kidney disease. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240829112855/en/ Humana Medicare Advantage members who qualify for the program will now have access to a team of Evergreen professionals who work together in partnership with their nephrologist to provide individualized, whole-person care. Evergreen has nephrology practice partnerships in the following
CenterWell Home Health, one of America's largest home health providers, has launched its 20th annual Food Fundraising Drive, an effort to fight food insecurity in the communities it serves. Through Sept. 21, CenterWell Home Health branches across the country will be collecting food and funds to benefit local food banks in the 38 states it serves. CenterWell is also partnering with the national organization Feeding America to offer a single website to collect financial contributions from people wherever they are: CenterWell Home Health - Fundraising For Feeding America. Over the years, CenterWell Home Health has collected and donated more than 1.3 million meals to people in need. Accor
Builds On Ongoing Collaboration With Google Health To Develop Population Health Solutions And Address Healthcare Challenges
TD Cowen analyst Gary Taylor maintains Humana (NYSE:HUM) with a Buy and raises the price target from $396 to $407.
Cantor Fitzgerald analyst Sarah James reiterates Humana (NYSE:HUM) with a Neutral and maintains $360 price target.
Healthcare investors are expecting Republican presidential nominee Donald Trump to ease regulations on Medicare Advantage if the former president wins and returns to the White House. Under the Biden administration, the Centers for Medicare & Medicaid Services has hardened its stance on the program after it faced criticism for insurers overbilling the government and denying care to seniors too many times, the Wall Street Journal reported. Republicans tend to favor privatizing government services and have been friendlier to Medicare Advantage plans, a trend that investors are betting could continue under a second Trump administration. Also Read: UnitedHealth Analysts Boost Their Fore
Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion. The decrease was driven by attrition in Medicaid membership, partially offset by higher premium yields reflecting the medical cost trend and growth in CarelonRx product revenue related to members served. Related: Morgan Stanley Says Elevance Health’s Growth Attributed To Consistent Performance But Undervalued. Premiums fell 3.2% to $35.42 billion, and product revenue rose 14% to $5.53 billion. Services fees increased 18% to $2.28 billion. “Second quarter results reflect the power of our diversified business and thoughtful
In the preceding three months, 11 analysts have released ratings for Humana (NYSE:HUM), presenting a wide array of perspectives from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 7 0 0 Last 30D 0 0 1 0 0 1M Ago 0 1 1 0 0 2M Ago 0 0 3 0 0 3M Ago 1 2 2 0 0 In the assessment of 12-month price targets, analysts unveil insights for Humana, presenting an average target of $369.64, a high estimate of $400.00, and a low estimate of $326.00. A 2.18% drop is evident in the curren
Truist Securities analyst David Macdonald maintains Humana (NYSE:HUM) with a Hold and raises the price target from $355 to $400.
Humana (NYSE:HUM) has outperformed the market over the past 20 years by 8.18% on an annualized basis producing an average annual return of 16.6%. Currently, Humana has a market capitalization of $45.73 billion. Buying $100 In HUM: If an investor had bought $100 of HUM stock 20 years ago, it would be worth $2,206.34 today based on a price of $379.49 for HUM at the time of writing. Humana's Performance Over Last 20 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated content engine and reviewed by an
8-K - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)
10-Q - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)
11-K - HUMANA INC (0000049071) (Filer)
11-K - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)
10-Q - HUMANA INC (0000049071) (Filer)
Piper Sandler downgraded Humana from Overweight to Neutral and set a new price target of $274.00 from $392.00 previously
BofA Securities downgraded Humana from Neutral to Underperform and set a new price target of $247.00 from $376.00 previously
Leerink Partners downgraded Humana from Outperform to Market Perform and set a new price target of $250.00 from $400.00 previously
Stephens downgraded Humana from Overweight to Equal-Weight and set a new price target of $250.00 from $400.00 previously
Piper Sandler initiated coverage of Humana with a rating of Overweight and set a new price target of $392.00
Morgan Stanley initiated coverage of Humana with a rating of Equal-Weight and set a new price target of $374.00
BofA Securities downgraded Humana from Buy to Neutral and set a new price target of $342.00 from $470.00 previously
BofA Securities downgraded Humana from Buy to Neutral
Raymond James initiated coverage of Humana with a rating of Mkt Perform
Argus downgraded Humana from Buy to Hold
David Dintenfass to lead new centralized function focused on customer experience, sales and marketing Leading health insurer and health care services company Humana Inc. (NYSE:HUM) announced today that it has named David Dintenfass as President of Enterprise Growth. In this new role, Dintenfass will have responsibility for leading the company's growth plan with a primary focus on customer acquisition, retention, and experience. The creation of this position, and its emphasis on the customer and digital experience, will help Humana deliver on its long-term strategy and maximize long-term growth within the Medicare Advantage market. By 2030, one in five Americans is projected to be 65 years
Broussard, who reimagined senior-focused health care, announces he will step down after more than a decade of serving at the helm of the company Leading health insurer and health care services company Humana Inc. (NYSE:HUM) announced today it has named health care industry veteran Jim Rechtin as President and Chief Operating Officer of Humana Inc., effective January 8, 2024, as part of a long-planned CEO transition. He will report to Bruce Broussard, CEO, until the latter half of 2024 at which time Broussard will step down and Rechtin will assume the CEO role. Broussard joined Humana in 2011 and assumed the role of CEO in 2013. Over the last decade, he has led the company's transformati
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE:HUM) for the past 41 years, today announced that David A. Jones Jr. has been elected to serve as Chairman of the Board of Directors, effective as of April 1, 2023. Jones is a current board member with over 26 years of dedicated service to the Humana Foundation. Since 1993, Jones has served on the Board of Directors for Humana Inc., a position from which he recently decided to retire as of April 20, 2023. "I am beyond honored with the opportunity to lead the Humana Foundation board and to further the 40-year history of the Foundation in Louisville, Kentucky and beyond as the foundation's reach has expanded nationally," said Mr.
4 - HUMANA INC (0000049071) (Issuer)